Видео ютуба по тегу Nct00934544

Current research into JAK inhibitors - specifially ruxolitinib, pacritinib, and momelotinib
Current research into JAK inhibitors - specifially ruxolitinib, pacritinib, and momelotinib
Cytokines and their impact on the severity of myelofibrosis
Cytokines and their impact on the severity of myelofibrosis
The impact of early ruxolitinib treatment on OS in the COMFORT-I and COMFORT-II studies
The impact of early ruxolitinib treatment on OS in the COMFORT-I and COMFORT-II studies
Dr Klisovic on the Early Use of JAK Inhibitors in Younger Patients With Low-Risk Myelofibrosis
Dr Klisovic on the Early Use of JAK Inhibitors in Younger Patients With Low-Risk Myelofibrosis
JAK inhibition for the early treatment of myelofibrosis
JAK inhibition for the early treatment of myelofibrosis
The role of ruxolitinib in the treatment of early-stage myelofibrosis
The role of ruxolitinib in the treatment of early-stage myelofibrosis
Analyses from COMFORT trials of ruxolitinib for myelofibrosis
Analyses from COMFORT trials of ruxolitinib for myelofibrosis
Электровоз ЭП20-003 с поездом Деда Мороза проезжает платформу 43км
Электровоз ЭП20-003 с поездом Деда Мороза проезжает платформу 43км
Pros and cons of ruxolitinib for the treatment of MPNs
Pros and cons of ruxolitinib for the treatment of MPNs